For many Australian and Canadian listed companies, Germany has traditionally been viewed as little more than a secondary trading venue following a Frankfurt listing.
That perception is changing rapidly.
Germany is now home to more than 12 million direct equity investors, while millions more invest through ETFs, online brokers and savings plans. Combined with Austria and Switzerland, the DACH region represents one of Europe's largest and most active retail investment markets. More importantly, today's German investors are increasingly looking beyond domestic companies in search of global growth opportunities.
Recent trading activity across German exchanges including Tradegate, Frankfurt, Stuttgart and Lang & Schwarz provides a fascinating snapshot of where retail capital is flowing. Rather than focusing purely on company size or geography, investors are increasingly allocating capital around long-term structural investment themes.
For Australian and Canadian companies seeking to diversify their shareholder base, these trends provide valuable insight into where investor attention is concentrated.
Gold remains Germany's favourite global investment theme
If one trend stands above all others, it is the continued strength of precious metals.
Among the most actively traded Australian and Canadian companies on German exchanges are numerous gold and silver producers, including Barrick Mining, Agnico Eagle Mines, Kinross Gold, Alamos Gold, Equinox Gold, Pan American Silver, Wheaton Precious Metals, First Majestic Silver, Northern Star Resources, Westgold Resources, Bellevue Gold, Perseus Mining, Eldorado Gold, B2Gold and a growing number of junior exploration companies.
This reflects more than simply higher bullion prices.
German investors have traditionally viewed precious metals as a hedge against inflation, geopolitical uncertainty and currency risk. Today's environment of elevated sovereign debt, central bank gold purchases and ongoing geopolitical tensions has only reinforced that conviction.
Importantly, investor demand extends well beyond established producers. Exploration companies with compelling development stories are also attracting meaningful trading activity as investors seek leverage to rising precious metal prices.
Critical minerals continue to attract strong investor attention
Another dominant theme is the growing importance of critical minerals.
Rare earths, lithium, graphite, tungsten, niobium and battery materials feature prominently among the most actively traded Australian and Canadian companies on German exchanges.
Names including Lynas Rare Earths, Arafura Rare Earths, St George Mining, Vulcan Energy, EcoGraf, European Lithium, Pensana, American Rare Earths, Almonty Industries, American Tungsten, Rock Tech Lithium and Standard Lithium all demonstrate the breadth of investor interest.
The reasons are clear.
Artificial intelligence infrastructure, electric vehicles, renewable energy, advanced manufacturing and Europe's expanding defence sector all require secure supplies of strategic raw materials. At the same time, the European Union's Critical Raw Materials Act has significantly increased awareness of companies capable of supplying these strategically important commodities.
Rather than viewing mining purely as a cyclical sector, German investors are increasingly recognising critical minerals as a long-term structural investment theme.
Defence has become one of Europe's fastest-growing investment sectors
Perhaps the most dramatic change over the past three years has been the transformation in investor attitudes towards defence.
Companies such as DroneShield and Electro Optic Systems have become among the most actively traded Australian stocks on German exchanges, reflecting Europe's rapidly changing geopolitical landscape.
As defence spending accelerates across NATO member states, retail investors are increasingly seeking exposure to technologies including drones, electronic warfare, autonomous systems, cybersecurity and dual-use technologies.
For many investors, defence is no longer viewed as a short-term geopolitical trade but as a long-term industrial growth sector.
AI and quantum computing continue capturing investor imagination
Artificial intelligence remains one of the defining investment themes globally.
However, German investors are increasingly looking beyond the large US technology companies and towards businesses enabling the next generation of AI infrastructure.
Semiconductor developers, cybersecurity companies, digital infrastructure providers and emerging quantum computing businesses are all attracting growing attention.
Companies such as BrainChip, Weebit Nano, Quantum eMotion and HIVE Digital Technologies demonstrate that investors are increasingly seeking earlier-stage opportunities that could benefit from AI's long-term expansion.
As enterprise adoption of quantum computing gradually accelerates, companies developing commercial applications in optimisation, cybersecurity and industrial software may become increasingly relevant to European investors.
European investors are investing in themes—not countries
Perhaps the most important lesson from current trading activity is that German retail investors are becoming increasingly thematic in their investment approach.
Very few investors wake up intending to buy an Australian or Canadian company simply because of its country of listing.
Instead, they seek exposure to long-term global trends.
Gold.
Critical minerals.
Artificial intelligence.
Quantum computing.
Defence technologies.
Healthcare innovation.
Companies operating in these sectors already begin with a significant advantage.
However, obtaining a Frankfurt listing alone is rarely enough.
The companies generating the strongest European trading activity are typically those that maintain ongoing engagement with investors through local-language news flow, financial media coverage, webinars, management interviews and regular communication with the market.
Visibility creates awareness.
Awareness creates liquidity.
Liquidity attracts new investors.
The opportunity continues to grow
Germany and the wider DACH region remain one of the world's most underappreciated sources of international retail investment capital.
As European investors continue searching for exposure to global growth sectors, Australian and Canadian companies operating in strategically important industries have a significant opportunity to broaden their shareholder base beyond domestic markets.
The trading activity currently visible across German exchanges suggests that investor appetite is already there.
For companies prepared to invest in sustained European investor engagement, the opportunity may be considerably larger than many boards currently appreciate.
 

European investor engagement has evolved rapidly over the past few years. While Europe remains one of the deepest and most sophisticated capital markets globally, success today requires far more than a roadshow or a single announcement. The companies that consistently attract attention, liquidity, and long-term shareholders are those that treat investor engagement as an ongoing, multi-channel strategy built on credible content, local relevance, and consistent visibility.

From working for many years with listed companies across Europe, Australia, North America, and Asia, one point is clear: content creation and distribution sit at the centre of successful European investor engagement.

European investors—particularly in German-speaking markets—are highly information-driven. They expect regular, high-quality updates that go beyond regulatory disclosures and help them understand strategy, execution, and long-term value creation.

Dr Reuter Investor Relations is a very well respected German based IR firm we are fortunate to be associated with. They have extensive experience with article content, creation and distribution. For many companies, this means publishing two to three editorial articles per week, tailored specifically to the European investor audience. These articles are not promotional in nature; they are informative, transparent, and written in a way that aligns with how European retail and institutional investors consume financial information. Importantly, content is only valuable if it reaches the right audience. That is why distribution is just as critical as creation.

Client content is disseminated by Dr Reuter IR across major German financial platforms, including Wallstreet and Ariva, among others. These platforms reach highly engaged investor communities, with individual articles often generating thousands of reads. Over time, this cadence builds familiarity, credibility, and an investor following that cannot be achieved through one-off campaigns.
Beyond written content, interactive engagement formats have become increasingly important. European investors value access to management and the opportunity to ask questions directly, particularly when travel is impractical or inefficient. Webinars, round tables, and virtual investor events now form a core part of modern IR strategies.

Recently, Dr Reuter Investor Relations partnered with AIRTIME to host a virtual drone technology investor conference, bringing together international investors, analysts, and industry participants focused on drones, robotics, and aerospace technology. The event demonstrated how targeted virtual formats can deliver real value: curated audiences, professional moderation, efficient time commitments, and meaningful dialogue—all without the cost and complexity of physical events. For participating companies, this translated into high-quality exposure to more than 2,000 relevant market participants and reinforced positioning as innovative, forward-looking businesses.

These kinds of events work best when they are embedded within a broader engagement strategy. A virtual conference or webinar should not be a standalone initiative, but rather part of a wider narrative supported by ongoing editorial coverage, media placement, and follow-up investor communication.

In a recent Matthew Reynolds delivered on successful European investor engagement, we highlighted several recurring themes we see among companies that perform well in the region. First, consistency matters more than intensity. Investors respond better to regular, predictable communication than sporadic bursts of activity. Second, localisation is essential. Messaging must reflect European market expectations, language nuances, and investment culture. Finally, credibility is built through transparency and education, not hype.

European capital markets reward companies that take the time to explain their business model, strategy, and milestones clearly and repeatedly. This applies equally to growth companies seeking to build awareness and to more established issuers looking to broaden and deepen their shareholder base.
Looking ahead, we believe the most successful IR teams will continue to blend traditional investor relations with modern content-driven approaches. Editorial articles, CEO interviews, webinars, and virtual round tables are no longer optional add-ons—they are core tools for engaging today’s European investors.

For global companies considering how to strengthen European investor engagement in 2025 and beyond, we encourage holistic strategy: content, distribution, interaction, and consistency.
​
When these elements work in unison companies can significantly enhance visibility, liquidity, and long-term investor support in Europe.

As the global race for clean energy and electrification accelerates, Europe finds itself at a crossroads.
The continent’s ambitions to lead in electric vehicles (EVs), renewable energy, and advanced manufacturing are under pressure due to a critical supply chain bottleneck: rare earth elements. These metals—particularly neodymium and praseodymium (NdPr)—are essential for EV motors, wind turbines, and other high-tech applications. Yet the European Union (EU) sources nearly all its rare earths from a single country - China.

China currently controls around 60% of global rare earth mining and over 90% of the processing capacity. For the EU, this dependency translates into significant vulnerability. Recent Chinese export controls on rare earth magnets and upstream materials have reinforced these concerns.

In April 2025, Beijing introduced new export licensing rules that led to temporary delays in shipments, sending ripples through EU industrial supply chains. From EV manufacturing to wind turbine assembly, the risk of supply interruptions has triggered urgent calls for diversification and resilience.

Several European auto-supplier plants have already shut down, with more outages coming, said the region's auto supplier association, CLEPA. The average electric vehicle uses about .5 kg of rare earths elements, and a fossil-fuel car uses just half that, according to the International Energy Agency.

German headquartered wind turbine maker Siemens Gamesa is looking to reduce its dependence on China in some critical parts of its supply chain with the company nearly 100% dependent on China for rare earths and permanent magnets, which are among the critical materials needed to make wind turbines.

Strategic Response: Policy, Partnerships, and the Critical Raw Materials Act

The EU has responded with a multifaceted strategy. Central to this is the Critical Raw Materials Act (CRMA), introduced in 2023. The Act sets ambitious 2030 targets: extracting at least 10% of critical raw materials domestically, processing 40% within the EU, and recycling 25%. It also aims to ensure no more than 65% of the EU's annual consumption of any strategic raw material comes from a single country.

While these targets are a long way from being met—especially for rare earths—they have galvanized action. The EU is investing in mining and refining projects, supporting recycling infrastructure, and developing strategic partnerships with resource-rich countries like Namibia, Canada, and Australia. Notably, Sweden recently announced the discovery of Europe’s largest rare earth deposit, though commercial production remains years away.

Building Resilient Supply Chains: Offtake Agreements in Action

European industries are also taking direct action. Companies are signing offtake agreements with rare earth producers outside China to lock in long-term supplies.

• Siemens Gamesa Renewable Energy has signed a five-year binding offtake agreement with Arafura Rare Earths (ASX: ARU) to supply neodymium-praseodymium oxide from the Nolans project in Australia. The material will feed directly into Siemens Gamesa’s wind turbine magnet production in Germany, helping shield European renewables from Chinese supply risk.
• Schaeffler, the German automotive supplier, secured a five-year agreement with Norway’s REEtec to supply rare earth oxides starting in 2024. This marks a milestone in Europe’s effort to build a rare earth value chain entirely outside of China.
• Hastings Technology Metals (ASX: HAS) has entered a 10-year offtake agreement with thyssenkrupp Materials Trading for the supply of up to 70,000 tonnes of rare earth carbonate from its Yangibana project in Western Australia. The deal guarantees 9,000 tonnes per year for the first five years and 5,000 tonnes annually for the next five. Thyssenkrupp will have exclusive global distribution rights, except for a few existing customers. The material—rich in neodymium and praseodymium—will support a broad range of EU clean tech applications.
• Australian Strategic Materials (ASX: ASM) has received a purchase order from Vacuumschmelze (VAC), a leading German based global manufacturer of magnetic materials and solutions. VAC has ordered 7.2 tonnes of neodymium-iron-boron (NdFeB) alloy across five custom specifications. This agreement builds on successful validation of ASM's materials and reflects the deepening strategic relationship between ASM and VAC, reinforcing Europe's downstream magnet supply resilience.

We expect further European interest in Kazakhstan and Brazil where several Australian companies are developing world class projects.

The Road Ahead

As Europe scales up its electrification and climate goals, reducing rare earth dependency on China has become not just an economic necessity, but a strategic imperative. The combination of policy initiatives, international partnerships, and forward-looking industry contracts is laying the foundation for a more resilient supply chain.

The EU’s efforts to diversify and secure rare earth supply are already influencing global investment flows and reshaping industrial strategies. By locking in new sources and investing in processing, Europe is moving toward a future where its green and digital ambitions are not held back by critical material shortages.
​

Several publicly listed Australian life science companies have demonstrated strong European growth and performance, highlighting what is a key export success for Australia.

Industry leaders across biotechnology, pharmaceuticals, medical technology, and diagnostics – from giants like CSL and ResMed to emerging players – are leveraging European operations to drive growth.
Below we examine the market strategies and European expansion activities of these companies.

CSL: Biotech Leader Expands Footprint in Europe

CSL Ltd (ASX: CSL), Australia’s largest biopharmaceutical company, reported a net profit of US$2.91 billion for the 2024 fiscal year, an 11% increase in constant currency over the prior year.

Strategically, CSL’s 2022 acquisition of Switzerland-based Vifor Pharma has bolstered its European presence. The newly formed CSL Vifor division delivered modest growth in iron therapy sales and is continuing to grow volume in Europe despite generic entrants.  CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, starting in Switzerland.

This European contribution helped CSL exceed forecasts and reinforced its confidence in sustaining double-digit earnings growth in the medium term. The Vifor integration, along with CSL’s flu vaccine unit Seqirus, has solidified CSL’s footprint across EU markets as it executes on global expansion plans.

ResMed: Strengthening European Market Position

ResMed (ASX: RMD), a global leader in sleep apnoea and respiratory devices founded in Australia, has also seen solid success in Europe over the past year.

ResMed expanded strategically beyond devices: it acquired Germany’s MEDIFOX-DAN in late 2022, a €958 million out-of-hospital care software firm. This move boosted ResMed’s software-as-a-service segment in Europe.

Europe is a vital market for ResMed, where the company maintains strategic hubs across key countries including France, Germany, the United Kingdom, Spain, and the Netherlands. These hubs support core operations such as sales, marketing, customer service, and research and development. In addition, ResMed collaborates closely with healthcare professionals and providers throughout Europe to ensure broad access to its respiratory care solutions and digital health services.

Cochlear: Hearing Technology Gains Ground in Europe

Cochlear (ASX: COH) is an Australian-based maker of implantable hearing devices.

In 2024 the company announced strong growth in the US and Western Europe following the launch of its new Nucleus 8 sound processor. This product launch spurred market growth and share gains in Europe, as Western European clinics adopted the Nucleus 8 for both adult and paediatric patients.
​
The European market for cochlear implants is experiencing significant growth, with an estimated 500,000 users and around 25,000 new implants each year.

Sonic Healthcare: Diagnostics Expansion Across Europe

Sonic Healthcare, a large Australian medical diagnostics company, has pursued an ambitious European growth strategy while navigating a post-COVID landscape.

In late 2024, Sonic announced a deal to acquire Germany’s LADR laboratory group for €423 million, adding roughly €370 million in annual revenue and broadening Sonic’s footprint in Germany, Poland, and Finland.
This followed a series of smaller acquisitions – about A$655 million worth – of lab practices in Germany, Switzerland and other markets, further strengthening Sonic’s European presence.
​
The LADR deal was one of the largest acquisitions Sonic has made as it seeks to ramp up its presence in Europe and save pathology costs by merging with other players. One analyst predicted the deal would give Sonic 30 to 35 per cent market share in Germany, one of its core markets.
Sonic Healthcare made 20 per cent of its revenue from Germany in the fiscal 2024 year, the company’s third-largest market after the US at 24 per cent and Australia at 22 per cent.

Telix’s Rapid Growth in Europe

Telix Pharmaceuticals (ASX: TLX) continues to grow European sales. The company’s flagship product Illuccix (a prostate cancer imaging radiopharmaceutical) gained adoption across Europe following regulatory approvals.

Trajan Group: Expanding Analytical Science in Europe

Trajan Group Holdings (ASX: TRJ), an Australian developer and manufacturer of analytical and life sciences products, has been making significant strides in the European market. The company operates a German subsidiary, Trajan Europe GmbH, which plays a pivotal role in its European operations.

Trajan's European operations, particularly through its German subsidiary, are integral to its global strategy. The company's focus on analytical science and life sciences products aligns well with the European market's demand for precision and innovation in these fields.

Summary

The Australian life sciences sector is a vey strong global growth engine that looks set to continue to develop as the likes of Telix Pharmaceuticals and Mesoblast look to become global players in their respective fields.
​
European retail, sophisticated and institutional investors have also shown an appetite for these ASX listed companies with solid buying on German markets for their dual-listed securities.
​

The Australian Financial Review wrote a very interesting article in March (18 March 2025 "Gold price fever pitch as fundies spruik 100pc gains") that Australian fund managers are racing to launch gold-focused investment funds, seizing on record-breaking prices that have pushed bullion past $US3000 an ounce for the first time. Gold has climbed more than 14% in 2025 alone, and 40% over the past year, with major banks repeatedly raising their forecasts.

While gold stocks had lagged due to cost pressures, they are now gaining ground. The NYSE Arca Gold Miners Index is up 30.8% this year, with the ASX equivalent rising 29%.

Collins St Asset Management is reopening its Special Situations Fund to new investors after a near 80% surge in 12 months, claiming select small- to mid-cap stocks could double in value if gold remains strong.
L1 Capital has also launched a gold fund, targeting mid-cap companies in Australia and North America, using a long/short strategy to balance gains with downside protection. Notable holdings include Westgold Resources and Eldorado Gold.

Meanwhile, the Victor Smorgon Group has debuted a second gold fund, eyeing returns over 50% in 18 months. Portfolio manager Cameron Judd believes the strategy’s concentrated picks of global miners offer “exceptional upside with low downside risk.” He also warned that Trump-era tariffs could spur stagflation, pushing gold to $US3600 an ounce.

Macquarie and Bank of America share similar views, lifting long-term price targets to $US3500. Investor sentiment has followed suit, with net buying of gold ETFs this year reversing a four-year trend. February saw the largest monthly inflows into North American ETFs since July 2020, partly driven by a price arbitrage between New York and London markets.
​
To meet growing local demand, Global X is launching a new ETF tracking gold in Australian dollars, set to begin trading by the end of March.

A 2024 study by the World Gold Council found that 38% of German investors have bought or held gold—making it the third most popular investment after savings accounts and stocks. Their reasons echo those of central banks and institutional investors: gold protects against inflation, is easy to trade, offers better long-term returns than cash, and helps diversify portfolios.

As of April 21, 2025, gold prices have soared past US $3,400 per ounce—a record high. The 12% gain in the past month and 45% jump over the past year is driven by safe-haven demand amid global trade tensions and a weakening U.S. dollar.

Germany’s deep-rooted relationship with gold remains strong. The Deutsche Bundesbank holds the world’s second-largest gold reserves, behind only the U.S. Federal Reserve. These reserves reflect both strategic foresight and a cultural memory shaped by hyperinflation and economic turmoil, reinforcing gold’s appeal as a stable, tangible asset.

Germany's affinity for gold—rooted in history, economics, and psychology—continues to shape both private and institutional investment strategies as the global outlook remains uncertain.

BNP Paribas recently highlighted five reasons for continued bullishness on gold and these are some of the reasons also cited by German gold investors.

1. Central Bank Activity
   The global easing cycle and central bank gold purchases are expected to continue supporting prices.
2. Economic Policies
   Inflationary government policies, rising deficits, and trade concerns bolster gold's safe-haven appeal.
3. Geopolitical Tensions
   Ongoing conflicts in regions like Ukraine and the Middle East maintain uncertainty.
4. Market Trends
   Despite short-term corrections, long-term fundamentals—such as dovish central bank policies—remain positive.
5. Investor Demand
   Strong interest from retail and institutional buyers persists. ETF holdings remain 25% below 2020 highs, and China’s central bank resumed gold purchases in late 2024.

Most Actively Traded Dual-Listed Gold Miners on Frankfurt and German Stock Exchanges.
German and European investors continue to be very strong buyers of global gold exploration and mining companies with a dual listing on Frankfurt Stock Exchange.
Some of these include:​

On 25 March 2025, the European Commission unveiled a list of 47 Strategic Projects under the Critical Raw Materials Act (CRMA). These initiatives aim to fortify the EU’s critical raw materials value chains and enhance the bloc’s strategic autonomy in securing essential resources.
Understanding the CRMA and the Role of Strategic Projects
The Critical Raw Materials Act, which entered into force in May 2024, is a cornerstone of the EU’s strategy to address growing concerns around the supply of key raw materials essential for technologies in renewable energy, defense, batteries, and aerospace. Materials such as lithium, cobalt, and nickel are vital, but the EU currently relies heavily on third countries for their supply, processing, and recycling.
To address these vulnerabilities, the CRMA establishes clear benchmarks to be met by 2030:

• At least 10% of the EU's annual consumption from domestic extraction
  
• At least 40% from domestic processing
  
• At least 25% from domestic recycling
  
• No more than 65% of the EU’s annual consumption to come from a single third country
  

To help achieve these goals, the CRMA provides a dedicated framework for the identification and support of Strategic Projects—initiatives considered essential for the secure and sustainable supply of critical raw materials within the EU.
Selection and Benefits of Strategic Projects
Applications for Strategic Project status opened in 2024. Projects were evaluated by independent experts based on technical feasibility, financial and sustainability metrics, alignment with CRMA criteria, and classification under the United Nations Framework Classification for Resources.
Following this initial assessment, the European Commission created a shortlist, which was then reviewed by the Critical Raw Materials Board—composed of representatives from EU Member States and the European Parliament (as an observer). After consultation, the final list of 47 Strategic Projects was formally adopted.
These projects benefit from two significant advantages:

1. Streamlined Permitting:
   Permitting timelines are significantly shortened. Extraction projects must receive permits within 27 months, while other project types have a maximum timeline of 15 months—far quicker than the standard five to ten years typically required.
   
2. Enhanced Access to Finance:
   Collectively requiring an estimated €22.5 billion in investment, these projects will benefit from advisory support by the CRMA’s financing sub-group, which includes the European Investment Bank (EIB) and other financial stakeholders. Additional funding may also be accessed via the European Regional Development Fund and the Cohesion Fund.
   

Although the real-world impact of these benefits remains to be fully seen, the Strategic Project label offers project developers improved financing prospects, targeted guidance, and regulatory predictability—key advantages in a competitive global landscape.
A Snapshot of the 47 Strategic Projects
The designated Strategic Projects span 13 EU Member States and reflect diverse stages of the raw materials value chain:

• Extraction: 25 projects
  
• Processing: 24 projects
  
• Recycling: 10 projects
  
• Substitution of critical materials: 2 projects
  

In terms of materials, the projects are focused on:

• Lithium: 22 projects
  
• Nickel: 12 projects
  
• Graphite: 11 projects
  
• Cobalt: 10 projects
  
• Manganese: 7 projects
  
• Tungsten: 3 projects
  
• Magnesium: 1 project
  

Looking Ahead
The designation of these 47 projects marks a significant milestone in the EU's efforts to secure the raw materials that underpin its green and digital transitions. As implementation begins, close attention will be paid to how effectively these projects are supported—and how they help reshape the EU's strategic position in global supply chains.

Australian Projects
​
The following projects have been awarded Strategic Projects status where there is an ASX listed company involved:

• Vulcan Energy’s (ASX: VUL) Lionheart Project (in Germany): A geothermal lithium project combining extraction and conversion with net-zero emissions.
• Talga Group’s (ASX: TLG) graphite mine (in Sweden): A natural graphite operation supplying anode material to European battery makers.
• European Metals’ (ASX: EMH) Cinovec lithium project (in Czech Republic): Europe’s largest hard rock lithium resource.

Germany’s outgoing parliament on Tuesday approved a sweeping increase in government borrowing, passing legislation that includes significant changes to the country’s strict debt rules. The move is aimed at bolstering defense capabilities and reviving economic growth in Europe’s largest economy.

The legislation, proposed by Chancellor-in-waiting Friedrich Merz’s conservatives and the center-left Social Democrats (SPD), outlines the creation of a €500 billion ($546 billion) fund dedicated to infrastructure development and economic recovery. It also includes changes to borrowing rules to support defense spending and aid for Ukraine.

To secure the necessary two-thirds majority, the coalition partners integrated last-minute demands from the Greens party, a key player in ongoing government formation talks following last month’s election. The legislation will now proceed to the Bundesrat, Germany’s upper house representing the country’s 16 states, which is expected to vote on Friday. Senior officials from the conservatives and the SPD have expressed confidence that the bill will pass.

According to Merz, leader of the center-right Christian Democratic Union (CDU), the exceptional borrowing is justified under the unique circumstances created by what he called “Vladimir Putin’s war of aggression against Europe.” Under the proposed package, defense spending exceeding one percent of GDP will be exempted from the constitutional debt brake, a move aimed at strengthening Germany’s military capabilities. Additionally, aid for Ukraine will fall under this exemption, potentially unlocking billions of euros for the embattled country.

“The decision we are taking today can therefore be nothing less than the first major step towards a new European defense community,” Merz stated. He emphasized the importance of involving non-EU countries such as the UK and Norway, while also advocating for European manufacturers to receive reliable and predictable defense orders.

Beyond defense, the package dedicates €500 billion to boosting Germany’s economy, with 20% of that amount committed to combating climate change — a critical demand of the Greens party. Furthermore, borrowing restrictions for Germany’s 16 states are to be relaxed, enabling billions more to be directed toward local infrastructure projects.
​
The adoption of this ambitious package marks a significant victory for the incoming coalition and is expected to provide financial stability over the coming years. Its success comes after the collapse of the previous SPD-led coalition government in November, partly due to fiscal challenges.
The Bundesrat’s vote on Friday will be the final hurdle for the transformative package, which promises to reshape Germany’s economic and defense landscape for years to come.

​In 2024 global biotech companies in Europe saw generally strong demand from European retail, sophisticated and institutional investors.

Interest was especially strong in those companies with a dual-listing on Frankfurt Stock Exchange.
Choosing the right IR partner in Europe is critical for companies looking to engage with, and nurture trust from, European investors.

Biotech investor relations (IR) is fundamentally different from IR in other industries. Unlike traditional companies valued on near-term profitability, biotech firms operate in a high-risk, long-term development cycle where value is tied to future potential rather than immediate revenue. Successfully engaging with the investment community requires a strategic, specialized approach.

We are seeing an increasing appetite from EU investors for quality global biotech and life sciences companies with a dual-listing on Frankfurt Stock Exchange.

Technology: Translating Innovation into Investor Confidence

A biotech company's technology is its most valuable asset, but early-stage biotech innovations are often unproven. A common pitfall is being too immersed in the science, making it difficult to clearly articulate your value proposition to investors.

The ability to explain your technology’s uniqueness, origins, and competitive advantage in a compelling yet accessible way is essential. While many biotech investors have scientific or medical backgrounds, your messaging must remain concise, strategic, and investment-focused.

We work with specialist biotech experts in Germany that create detailed articles in easy-to-understand language for German equity media publications.

Managing Risk: A Clear Roadmap Through Development and Regulation

Biotech investments come with inherent risks, from drug development and regulatory hurdles to commercial viability. Investors need to understand how your company plans to mitigate these risks.

A strong IR strategy requires a transparent and well-structured narrative, outlining your pathway through clinical development, regulatory approval, and market adoption. Clarity on these key milestones builds investor confidence and distinguishes your company from competitors.

Demonstrating Opportunity: Credibility and Market PotentialThe life sciences industry presents immense growth potential, but credibility is key when defining your market opportunity.

Investors expect biotech companies to provide realistic, data-backed projections of potential market size, adoption rates, and competitive positioning.

While bold projections can be persuasive, they must be defensible—your ability to justify revenue potential and peak sales estimates will directly impact how investors model your future value.

Meeting HNW/FO investors face-to-face in Europe is important. Many global companies present at EU events such as BioEurope and this also open up opportunities for an EU investor roadshow in cities such as Frankfurt, Munich or Zurich.

Financial Strategy: Planning for Capital Market Expectations

Most biotech companies rely on external funding throughout their lifecycle, requiring a proactive approach to capital markets. Investors anticipate strategic fundraising aligned with key milestones, such as positive Phase 2 or Phase 3 clinical data.

A well-structured IR strategy ensures your company is positioned for sustainable growth while meeting investor expectations for financial planning and execution.

When meeting DACH region HNW/FO investors it is important to be able to clearly articulate a company's capital requirements, strategy, cash flow management and vision.

Why the Right Investor Relations Partner Matters​

Given the complexity and unique challenges of biotech IR, choosing the right investor relations firm is crucial.

A strong European IR partner will not only help craft a compelling investment thesis for EU investors but also navigate market expectations, engage the right investors, and optimise your communications strategy.

With the right European IR strategy and support, your life sciences company can maximize European investor confidence, secure capital efficiently, and develop long-holding and engaged investors in Europe.

In Europe we collaborate with a company's home IR firm to ensure a clear and consistent message across global markets. We have deep relationships with DACH region financial journalists and article writers to nurture engagement and interest with biotech, life sciences and impact investors in Europe.
​
There are 12 million equity and ETF investors in Germany alone - this is an important market for biotech, medtech and life sciences companies to engage with.

h the increasing complexity of European capital markets and the digital-first mindset of today’s investors, it is vital to find a partner who understands how to excel in this evolving landscape.

In Germany - where we work with Australian, North American and UK companies to engage with European retail and sophisticated investor - the competition for investor dollars is the strongest it has ever been.
Excellence, connections, and on-ground expertise are essential.

We collaborate with Tier-1 German and European Investor Relations professionals and Roadshow providers and content creators to help ensure your European IR strategy is a success.

The New Era of Investor Relations

The digital revolution has reshaped how companies and investors interact.

Companies need to engage in real-time dialogue through webcasts, live chats, and digital platforms. The competition for investor attention is fierce, and a successful IR strategy must be holistic in nature.

An effective IR program is not just about quarterly updates – it involves nurturing and cultivating long-term relationships that withstand the market’s difficulties. Trust and credibility derive through consistent, transparent communication.

Investors should know a company’s narrative and strategy, believe in the board and management, and want to stay for the journey.

Building a successful investor relations strategy

Companies should look to an investor relations firm that brings expertise, creativity, and a deep understanding of how to connect with today’s investor.

1. A Strategic thinking: An IR firm should craft and communicate a compelling narrative and partner as architects of a communication strategy, ensuring every message strengthens the brand.
2. Storytelling Excellence: Every company should have a powerful story—one that needs to resonate with diverse investor audiences across different geographic regions. An IR professional should assist in articulating this story with clarity and impact.
3. Digital Mastery: In the digital age, an impactful online presence is non-negotiable. From building a dynamic IR website to leveraging mobile-friendly tools, a digital strategy should be robust and investor-friendly.
4. Social media: Platforms like LinkedIn and X are essential for engaging with today’s investors. A partner should be able to harness these tools to amplify your message and build deeper connections.
5. Interactive Engagement: Investors appreciate direct interaction. Through webcasts, live Q&A sessions, and other virtual tools, companies should embrace opportunities to demonstrate their leadership and vision.
6. Authenticity and Transparency: Investors value honesty and transparency. An IR partner should address the right balance between showcasing strengths and openly addressing challenges.
7. Data-Driven Insights: Companies should embrace actionable feedback from the investor community. Listening and responding to investors will build trust and strengthen our strategic position.
8. Consistent Communication: Beyond quarterly updates, companies should provide regular, meaningful touchpoints to demonstrate they are proactive and engaged in the relationship.

The Right Partner Can Be a Game-Changer
​
Here at Austlinx, we assist with our European partners to create a program to highlight a company’s strengths, establish trust, and engage with European retail, sophisticated and institutional investors.